APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Minimally Invasive Treatment of Lung Cancer

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Minimally Invasive Treatment of Lung Cancer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17442690024 July 2026195 pages

Choose your research edition.

Industry ResearchMinimally Invasive Treatment of Lung Cancer Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Minimally Invasive Treatment of Lung Cancer Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Minimally Invasive Treatment of Lung Cancer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Minimally Invasive Treatment of Lung Cancer Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Minimally Invasive Treatment of Lung Cancer Market Analysis and Forecast 2026-2032170 pages · $4,950 USD

Market perspective

The global Minimally Invasive Treatment of Lung Cancer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Minimally Invasive Treatment of Lung Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Minimally Invasive Treatment of Lung Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Minimally Invasive Treatment of Lung Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Minimally Invasive Treatment of Lung Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Minimally Invasive Treatment of Lung Cancer include Medtronic, LungCare, Broncus, Boston Scientific, Olympus, VISON Medical, Smith and Nephew, Nanjing MICRO-TECH and Intuitive Surgica, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Minimally Invasive Treatment of Lung Cancer market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Minimally Invasive Treatment of Lung Cancer and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Minimally Invasive Treatment of Lung Cancer revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Minimally Invasive Treatment of Lung Cancer market size, projected growth trends, production technologies, key applications, and end-use industries.

Minimally Invasive Treatment of Lung Cancer Segment by Company

Medtronic

LungCare

Broncus

Boston Scientific

Olympus

VISON Medical

Smith and Nephew

Nanjing MICRO-TECH

Intuitive Surgica

Auris Health

Angiodynamics

Minimally Invasive Treatment of Lung Cancer Segment by Type

Lung Tumor Ablation

Lung Tumor Embolization

Minimally Invasive Treatment of Lung Cancer Segment by Application

Hospitals

Ambulatory Surgical Centers

Minimally Invasive Treatment of Lung Cancer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Minimally Invasive Treatment of Lung Cancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Minimally Invasive Treatment of Lung Cancer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Minimally Invasive Treatment of Lung Cancer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Minimally Invasive Treatment of Lung Cancer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Minimally Invasive Treatment of Lung Cancer industry.

Chapter 3: Detailed analysis of Minimally Invasive Treatment of Lung Cancer companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Minimally Invasive Treatment of Lung Cancerrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Lung Tumor Ablation Table 3. Key Players of Lung Tumor Embolization Table 4. Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of Ambulatory Surgical Centers Table 7. Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Minimally Invasive Treatment of Lung Cancer Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Minimally Invasive Treatment of Lung Cancer Market Share by Region (2021-2026) Table 10. Global Minimally Invasive Treatment of Lung Cancer Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Minimally Invasive Treatment of Lung Cancer Market Share by Region (2027-2032) Table 12. Minimally Invasive Treatment of Lung Cancer Industry Trends Table 13. Minimally Invasive Treatment of Lung Cancer Industry Drivers Table 14. Minimally Invasive Treatment of Lung Cancer Industry Opportunities and Challenges Table 15. Minimally Invasive Treatment of Lung Cancer Industry Restraints Table 16. Global Minimally Invasive Treatment of Lung Cancer Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Company (2021-2026) Table 18. Global Minimally Invasive Treatment of Lung Cancer Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Minimally Invasive Treatment of Lung Cancer Key Company Head Office and Area Served Table 20. Global Minimally Invasive Treatment of Lung Cancer Company, Product Type & Application Table 21. Global Minimally Invasive Treatment of Lung Cancer Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Minimally Invasive Treatment of Lung Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Minimally Invasive Treatment of Lung Cancer Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Minimally Invasive Treatment of Lung Cancer Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Type (2021-2026) Table 28. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Type (2027-2032) Table 29. Global Minimally Invasive Treatment of Lung Cancer Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Minimally Invasive Treatment of Lung Cancer Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Application (2021-2026) Table 33. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Application (2027-2032) Table 34. Medtronic Company Information Table 35. Medtronic Business Overview Table 36. Medtronic Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Medtronic Minimally Invasive Treatment of Lung Cancer Product Portfolio Table 38. Medtronic Recent Development Table 39. LungCare Company Information Table 40. LungCare Business Overview Table 41. LungCare Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. LungCare Minimally Invasive Treatment of Lung Cancer Product Portfolio Table 43. LungCare Recent Development Table 44. Broncus Company Information Table 45. Broncus Business Overview Table 46. Broncus Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Broncus Minimally Invasive Treatment of Lung Cancer Product Portfolio Table 48. Broncus Recent Development Table 49. Boston Scientific Company Information Table 50. Boston Scientific Business Overview Table 51. Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Boston Scientific Minimally Invasive Treatment of Lung Cancer Product Portfolio Table 53. Boston Scientific Recent Development Table 54. Olympus Company Information Table 55. Olympus Business Overview Table 56. Olympus Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Olympus Minimally Invasive Treatment of Lung Cancer Product Portfolio Table 58. Olympus Recent Development Table 59. VISON Medical Company Information Table 60. VISON Medical Business Overview Table 61. VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. VISON Medical Minimally Invasive Treatment of Lung Cancer Product Portfolio Table 63. VISON Medical Recent Development Table 64. Smith and Nephew Company Information Table 65. Smith and Nephew Business Overview Table 66. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Product Portfolio Table 68. Smith and Nephew Recent Development Table 69. Nanjing MICRO-TECH Company Information Table 70. Nanjing MICRO-TECH Business Overview Table 71. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Product Portfolio Table 73. Nanjing MICRO-TECH Recent Development Table 74. Intuitive Surgica Company Information Table 75. Intuitive Surgica Business Overview Table 76. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Product Portfolio Table 78. Intuitive Surgica Recent Development Table 79. Auris Health Company Information Table 80. Auris Health Business Overview Table 81. Auris Health Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Auris Health Minimally Invasive Treatment of Lung Cancer Product Portfolio Table 83. Auris Health Recent Development Table 84. Angiodynamics Company Information Table 85. Angiodynamics Business Overview Table 86. Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Angiodynamics Minimally Invasive Treatment of Lung Cancer Product Portfolio Table 88. Angiodynamics Recent Development Table 89. North America Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021-2026) & (US$ Million) Table 90. North America Minimally Invasive Treatment of Lung Cancer Market Size by Type (2027-2032) & (US$ Million) Table 91. North America Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021-2026) & (US$ Million) Table 92. North America Minimally Invasive Treatment of Lung Cancer Market Size by Application (2027-2032) & (US$ Million) Table 93. North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026) Table 95. North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2027-2032) Table 96. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021-2026) & (US$ Million) Table 97. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Type (2027-2032) & (US$ Million) Table 98. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021-2026) & (US$ Million) Table 99. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Application (2027-2032) & (US$ Million) Table 100. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026) Table 102. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2027-2032) Table 103. China Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021-2026) & (US$ Million) Table 104. China Minimally Invasive Treatment of Lung Cancer Market Size by Type (2027-2032) & (US$ Million) Table 105. China Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021-2026) & (US$ Million) Table 106. China Minimally Invasive Treatment of Lung Cancer Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021-2026) & (US$ Million) Table 108. Asia Minimally Invasive Treatment of Lung Cancer Market Size by Type (2027-2032) & (US$ Million) Table 109. Asia Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021-2026) & (US$ Million) Table 110. Asia Minimally Invasive Treatment of Lung Cancer Market Size by Application (2027-2032) & (US$ Million) Table 111. Asia Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026) Table 113. Asia Minimally Invasive Treatment of Lung Cancer Market Size by Country (2027-2032) Table 114. South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021-2026) & (US$ Million) Table 115. South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Type (2027-2032) & (US$ Million) Table 116. South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021-2026) & (US$ Million) Table 117. South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Application (2027-2032) & (US$ Million) Table 118. South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026) Table 120. South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Minimally Invasive Treatment of Lung Cancer Product Image Figure 2. Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Minimally Invasive Treatment of Lung Cancer Market Share by Type: 2025 VS 2032 Figure 4. Lung Tumor Ablation Image Figure 5. Lung Tumor Embolization Image Figure 6. Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Minimally Invasive Treatment of Lung Cancer Market Share by Application: 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Ambulatory Surgical Centers Image Figure 10. Global Minimally Invasive Treatment of Lung Cancer Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 12. Global Minimally Invasive Treatment of Lung Cancer Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Minimally Invasive Treatment of Lung Cancer Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Minimally Invasive Treatment of Lung Cancer Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Type (2021-2032) Figure 19. Global Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Application (2021-2032) Figure 21. North America Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 22. North America Minimally Invasive Treatment of Lung Cancer Market Share by Type (2021-2032) Figure 23. North America Minimally Invasive Treatment of Lung Cancer Market Share by Application (2021-2032) Figure 24. North America Minimally Invasive Treatment of Lung Cancer Market Share by Country (2021-2032) Figure 25. United States Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 26. Canada Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 28. Europe Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 29. Europe Minimally Invasive Treatment of Lung Cancer Market Share by Type (2021-2032) Figure 30. Europe Minimally Invasive Treatment of Lung Cancer Market Share by Application (2021-2032) Figure 31. Europe Minimally Invasive Treatment of Lung Cancer Market Share by Country (2021-2032) Figure 32. Germany Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 33. France Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 35. Italy Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 36. Russia Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 38. China Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 39. China Minimally Invasive Treatment of Lung Cancer Market Share by Type (2021-2032) Figure 40. China Minimally Invasive Treatment of Lung Cancer Market Share by Application (2021-2032) Figure 41. Asia Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 42. Asia Minimally Invasive Treatment of Lung Cancer Market Share by Type (2021-2032) Figure 43. Asia Minimally Invasive Treatment of Lung Cancer Market Share by Application (2021-2032) Figure 44. Asia Minimally Invasive Treatment of Lung Cancer Market Share by Country (2021-2032) Figure 45. Japan Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 49. India Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 50. Australia Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Share by Country (2021-2032) Figure 55. Brazil Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 60. UAE Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 62. Chile Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Lung Tumor Ablation
  • Lung Tumor Embolization
Applications
  • Hospitals
  • Ambulatory Surgical Centers
Companies covered
  • Medtronic
  • LungCare
  • Broncus
  • Boston Scientific
  • Olympus
  • VISON Medical
  • Smith and Nephew
  • Nanjing MICRO-TECH
  • Intuitive Surgica
  • Auris Health
  • Angiodynamics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Lung Tumor Ablation
  5. 1.2.3 Lung Tumor Embolization
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Ambulatory Surgical Centers
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Minimally Invasive Treatment of Lung Cancer Growth Trends by Region
  12. 1.5.1 Global Minimally Invasive Treatment of Lung Cancer Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Minimally Invasive Treatment of Lung Cancer Market Size by Region (2021-2026)
  14. 1.5.3 Minimally Invasive Treatment of Lung Cancer Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Minimally Invasive Treatment of Lung Cancer Market Dynamics
  1. 2.1 Minimally Invasive Treatment of Lung Cancer Industry Trends
  2. 2.2 Minimally Invasive Treatment of Lung Cancer Industry Drivers
  3. 2.3 Minimally Invasive Treatment of Lung Cancer Industry Opportunities and Challenges
  4. 2.4 Minimally Invasive Treatment of Lung Cancer Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Minimally Invasive Treatment of Lung Cancer Revenue by Company (2021-2026)
  2. 3.2 Global Minimally Invasive Treatment of Lung Cancer Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Minimally Invasive Treatment of Lung Cancer Key Company Head office and Area Served
  4. 3.4 Global Minimally Invasive Treatment of Lung Cancer Company, Product Type & Application
  5. 3.5 Global Minimally Invasive Treatment of Lung Cancer Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Minimally Invasive Treatment of Lung Cancer Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Minimally Invasive Treatment of Lung Cancer Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Minimally Invasive Treatment of Lung Cancer Tier 1, Tier 2, and Tier 3
4 Minimally Invasive Treatment of Lung Cancer Market by Type
  1. 4.1 Global Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021-2032)
  3. 4.3 Global Minimally Invasive Treatment of Lung Cancer Market Size Share by Type (2021-2032)
5 Minimally Invasive Treatment of Lung Cancer Market by Application
  1. 5.1 Global Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021-2032)
  3. 5.3 Global Minimally Invasive Treatment of Lung Cancer Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Medtronic
  2. 6.1.1 Medtronic Company Information
  3. 6.1.2 Medtronic Business Overview
  4. 6.1.3 Medtronic Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Medtronic Minimally Invasive Treatment of Lung Cancer Product Portfolio
  6. 6.1.5 Medtronic Recent Developments
  7. 6.2 LungCare
  8. 6.2.1 LungCare Company Information
  9. 6.2.2 LungCare Business Overview
  10. 6.2.3 LungCare Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 LungCare Minimally Invasive Treatment of Lung Cancer Product Portfolio
  12. 6.2.5 LungCare Recent Developments
  13. 6.3 Broncus
  14. 6.3.1 Broncus Company Information
  15. 6.3.2 Broncus Business Overview
  16. 6.3.3 Broncus Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Broncus Minimally Invasive Treatment of Lung Cancer Product Portfolio
  18. 6.3.5 Broncus Recent Developments
  19. 6.4 Boston Scientific
  20. 6.4.1 Boston Scientific Company Information
  21. 6.4.2 Boston Scientific Business Overview
  22. 6.4.3 Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Boston Scientific Minimally Invasive Treatment of Lung Cancer Product Portfolio
  24. 6.4.5 Boston Scientific Recent Developments
  25. 6.5 Olympus
  26. 6.5.1 Olympus Company Information
  27. 6.5.2 Olympus Business Overview
  28. 6.5.3 Olympus Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Olympus Minimally Invasive Treatment of Lung Cancer Product Portfolio
  30. 6.5.5 Olympus Recent Developments
  31. 6.6 VISON Medical
  32. 6.6.1 VISON Medical Company Information
  33. 6.6.2 VISON Medical Business Overview
  34. 6.6.3 VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 VISON Medical Minimally Invasive Treatment of Lung Cancer Product Portfolio
  36. 6.6.5 VISON Medical Recent Developments
  37. 6.7 Smith and Nephew
  38. 6.7.1 Smith and Nephew Company Information
  39. 6.7.2 Smith and Nephew Business Overview
  40. 6.7.3 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Product Portfolio
  42. 6.7.5 Smith and Nephew Recent Developments
  43. 6.8 Nanjing MICRO-TECH
  44. 6.8.1 Nanjing MICRO-TECH Company Information
  45. 6.8.2 Nanjing MICRO-TECH Business Overview
  46. 6.8.3 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Product Portfolio
  48. 6.8.5 Nanjing MICRO-TECH Recent Developments
  49. 6.9 Intuitive Surgica
  50. 6.9.1 Intuitive Surgica Company Information
  51. 6.9.2 Intuitive Surgica Business Overview
  52. 6.9.3 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Product Portfolio
  54. 6.9.5 Intuitive Surgica Recent Developments
  55. 6.10 Auris Health
  56. 6.10.1 Auris Health Company Information
  57. 6.10.2 Auris Health Business Overview
  58. 6.10.3 Auris Health Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Auris Health Minimally Invasive Treatment of Lung Cancer Product Portfolio
  60. 6.10.5 Auris Health Recent Developments
  61. 6.11 Angiodynamics
  62. 6.11.1 Angiodynamics Company Information
  63. 6.11.2 Angiodynamics Business Overview
  64. 6.11.3 Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Angiodynamics Minimally Invasive Treatment of Lung Cancer Product Portfolio
  66. 6.11.5 Angiodynamics Recent Developments
7 North America
  1. 7.1 North America Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032)
  2. 7.2 North America Minimally Invasive Treatment of Lung Cancer Market Size by Type
  3. 7.2.1 North America Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021-2026)
  4. 7.2.2 North America Minimally Invasive Treatment of Lung Cancer Market Size by Type (2027-2032)
  5. 7.2.3 North America Minimally Invasive Treatment of Lung Cancer Market Share by Type (2021-2032)
  6. 7.3 North America Minimally Invasive Treatment of Lung Cancer Market Size by Application
  7. 7.3.1 North America Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021-2026)
  8. 7.3.2 North America Minimally Invasive Treatment of Lung Cancer Market Size by Application (2027-2032)
  9. 7.3.3 North America Minimally Invasive Treatment of Lung Cancer Market Share by Application (2021-2032)
  10. 7.4 North America Minimally Invasive Treatment of Lung Cancer Market Size by Country
  11. 7.4.1 North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026)
  13. 7.4.3 North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2027-2032)
  14. 7.4.4 North America Minimally Invasive Treatment of Lung Cancer Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032)
  2. 8.2 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Type
  3. 8.2.1 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021-2026)
  4. 8.2.2 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Type (2027-2032)
  5. 8.2.3 Europe Minimally Invasive Treatment of Lung Cancer Market Share by Type (2021-2032)
  6. 8.3 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Application
  7. 8.3.1 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021-2026)
  8. 8.3.2 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Application (2027-2032)
  9. 8.3.3 Europe Minimally Invasive Treatment of Lung Cancer Market Share by Application (2021-2032)
  10. 8.4 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country
  11. 8.4.1 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026)
  13. 8.4.3 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2027-2032)
  14. 8.4.4 Europe Minimally Invasive Treatment of Lung Cancer Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032)
  2. 9.2 China Minimally Invasive Treatment of Lung Cancer Market Size by Type
  3. 9.2.1 China Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021-2026)
  4. 9.2.2 China Minimally Invasive Treatment of Lung Cancer Market Size by Type (2027-2032)
  5. 9.2.3 China Minimally Invasive Treatment of Lung Cancer Market Share by Type (2021-2032)
  6. 9.3 China Minimally Invasive Treatment of Lung Cancer Market Size by Application
  7. 9.3.1 China Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021-2026)
  8. 9.3.2 China Minimally Invasive Treatment of Lung Cancer Market Size by Application (2027-2032)
  9. 9.3.3 China Minimally Invasive Treatment of Lung Cancer Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032)
  2. 10.2 Asia Minimally Invasive Treatment of Lung Cancer Market Size by Type
  3. 10.2.1 Asia Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021-2026)
  4. 10.2.2 Asia Minimally Invasive Treatment of Lung Cancer Market Size by Type (2027-2032)
  5. 10.2.3 Asia Minimally Invasive Treatment of Lung Cancer Market Share by Type (2021-2032)
  6. 10.3 Asia Minimally Invasive Treatment of Lung Cancer Market Size by Application
  7. 10.3.1 Asia Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021-2026)
  8. 10.3.2 Asia Minimally Invasive Treatment of Lung Cancer Market Size by Application (2027-2032)
  9. 10.3.3 Asia Minimally Invasive Treatment of Lung Cancer Market Share by Application (2021-2032)
  10. 10.4 Asia Minimally Invasive Treatment of Lung Cancer Market Size by Country
  11. 10.4.1 Asia Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026)
  13. 10.4.3 Asia Minimally Invasive Treatment of Lung Cancer Market Size by Country (2027-2032)
  14. 10.4.4 Asia Minimally Invasive Treatment of Lung Cancer Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst